Rheumatoide Arthritis – ein Handbuch - Phadia

Quellen
ACR Committee (2002) Guidelines for the Management of Rheumatoid Arthritis.
Arthritis Rheum 46, 328 – 346
Aho K, Palosuo T, Lukka M, Kurki P, Isomäki H, Kautiainen H, von Essen R (1999)
Antifilaggrin Antibodies in Recent-Onset Arthritis. Scand J Rheumatol 28,
113 – 116
Aletaha D, Smolen JS (2003) DMARD use in early rheumatoid arthritis. Lessons
from observations in patients with established disease. Clin Exp Rheumatol
21 (Suppl 31), S169 – S173
Andrew JG, Herrick AL, Marsh DR. Musculoskeletal Medicine and Surgery, 2000,
Churchill Livingstone, Edinburgh
Arbuckle MR, James JA, Kohlhase F, Rubertone MV, Dennis GJ, Harley JB (2001)
Development of anti-dsDNA autoantibodies prior to clinical diagnosis of
systemic lupus erythematosus. Scand J Immunol 54, 211 – 219
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA,
Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association
1987 revised criteria for the classification of rheumatoid arthritis.
Arthritis Rheum 31, 315 – 324
Baenkler H-W. Medizinische Immunologie, III-3.1 RA und verwandte Krankheitsbilder,
2001, Ecomed
Baeten D, Peene I, Union A, Meheus L, Sebagg M, Serre G, Veys EM, De Keyser F
(2001) Specific Presence of Intracellular Citrullinated Proteins in Rheumatoid
Arthritis Synovium. Arthritis Rheum 44, 2255 – 2262
Bas S, Perneger TV, Seitz M, Tiercy J-M, Roux-Lombard P, Guerne PA (2002) Diagnostic
tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated
peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors.
Rheumatology 41, 809 – 814
Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide
antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of
rheumatoid arthritis. Rheumatology 42, 677 – 680
131